683 Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28M | Buy |
219,000
+69,000
| +46% | +$717K | 0.15% | 85 |
|
|
2025
Q1 | $1.98M | Buy |
150,000
+25,000
| +20% | +$330K | 0.14% | 90 |
|
|
2024
Q4 | $2.24M | Buy |
125,000
+49,569
| +66% | +$888K | 0.14% | 77 |
|
|
2024
Q3 | $1.22M | Buy |
+75,431
| New | +$1.22M | 0.09% | 86 |
|
|
2021
Q1 | – | Sell |
-23,821
| Closed | -$2.17M | – | 210 |
|
|
2020
Q4 | $2.17M | Hold |
23,821
| – | – | 0.1% | 84 |
|
|
2020
Q3 | $1.77M | Hold |
23,821
| – | – | 0.13% | 72 |
|
|
2020
Q2 | $2.03M | Hold |
23,821
| – | – | 0.16% | 65 |
|
|
2020
Q1 | $1.72M | Buy |
+23,821
| New | +$1.72M | 0.2% | 62 |
|